National Cancer Institute to Grant Exclusive Patent License to University of the Sunshine Coast for Treating Skin Disorders

Summary

The National Cancer Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive, sublicensable patent license to the University of the Sunshine Coast, a public university in Queensland, Australia, for the use of its Tomentosenol technology in treating or preventing skin disorders.